EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Proteomic landscape of imipenem resistance in Pseudomonas aeruginosa: a comparative investigation between clinical and control strains

Marius Eidsaa, Animesh Sharma, Markus Janasch, Alicja Kuch, Anna Skoczyńska, Francesca Di Bartolomeo

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1623154 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Marius Eidsaa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway. Hauptthemen laut MEDLINE: Imipenem, Pseudomonas aeruginosa, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of antimicrobial resistance (AMR) poses a significant challenge to global health, particularly with bacterial pathogens such as Pseudomonas aeruginosa , a notorious cause of nosocomial infections. This study focuses on the comparative proteomic analysis of an imipenem-resistant strain of P. aeruginosa , a representative of world epidemic clone ST235, and a wildtype control strain, P. aeruginosa ATCC 27853, in response to varying concentrations of imipenem. Using label-free quantification (LFQ) and gene ontology (GO) enrichment analyses, we identified significant differences in the proteomic responses between the two strains. The clinical strain exhibited a stable proteomic profile across the imipenem gradient, suggesting pre-established and efficient resistance mechanisms that do not require extensive reconfiguration under antibiotic pressure. In contrast, the control strain showed a broader, more reactive proteomic response, particularly in proteins associated with membrane transport, stress response, and biofilm formation. Notably, uncharacterized proteins were significantly upregulated in the clinical strain, indicating potential novel resistance mechanisms. These findings highlight the distinct strategies employed by the two strains, with the clinical strain’s stable resistance mechanisms contrasting sharply with the control strain’s reactive approach. The study underscores the importance of further research into the uncharacterized proteins that may play crucial roles in antibiotic resistance, potentially leading to new therapeutic targets in the fight against AMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImipenemPseudomonas aeruginosaAnti-Bacterial AgentsDrug Resistance, BacterialProteomeBacterial ProteinsProteomicsPseudomonas InfectionsHumansMicrobial Sensitivity TestsBiofilms

Stichwörter der Autor:innen

Pseudomonas aeruginosaantibiotic challengeantimicrobial resistanceimipenemlabel-free quantitative proteomics

Substanzen

ImipenemAnti-Bacterial AgentsProteomeBacterial Proteins

Autor:innen und Institutionen

  • Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.
  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Proteomics and Modomics Experimental Core (PROMEC) at NTNU and the Central Norway Regional Health Authority, Trondheim, Norway.
  • Department of Epidemiology and Clinical Microbiology, National Medicines Institute (NMI), Warsaw, Poland.

Zitieren

APA

Eidsaa, M., Sharma, A., Janasch, M., Kuch, A., Skoczyńska, A., & Di Bartolomeo, F. (2025). Proteomic landscape of imipenem resistance in Pseudomonas aeruginosa: a comparative investigation between clinical and control strains. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1623154

Vancouver

Eidsaa M, Sharma A, Janasch M, Kuch A, Skoczyńska A, Di Bartolomeo F. Proteomic landscape of imipenem resistance in Pseudomonas aeruginosa: a comparative investigation between clinical and control strains. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1623154

BibTeX
@article{Eidsaa2025,
  author = {Eidsaa, Marius and Sharma, Animesh and Janasch, Markus and Kuch, Alicja and Skoczyńska, Anna and Di Bartolomeo, Francesca},
  title = {Proteomic landscape of imipenem resistance in Pseudomonas aeruginosa: a comparative investigation between clinical and control strains},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1623154}
}
Kostenlos starten →